Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis
Journal of Clinical Medicine · 31.07.2026 · 15 (15) · 5983
DOI: 10.3390/jcm15155983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.07.2026. Verfasst von Emilia Sorina Fiat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lucian Blaga University of Sibiu, “Lucian Blaga” University of Sibiu.
Abstract (Originalsprache)
Background/Objectives: Digoxin, a positive inotropic agent with a narrow therapeutic window, is used in heart failure but carries toxicity risks. This study aims to characterize the profile of digoxin-associated adverse drug reactions reported in the EudraVigilance database, focusing on drug–drug interactions, dosing errors, and off-label use.
Methods
Descriptive and disproportionality analyses were performed on Individual Case Safety Reports (ICSRs) until 25 January 2026. Digoxin was compared with other inotropic agents by calculating the Reporting Odds Ratio and 95% confidence intervals.
Results
Digoxin recorded 11,426 ICSRs, with a predominance in patients aged 65–85 years (46.4%) and over 85 years (25.1%). Higher reporting probabilities were identified for the terms “Drug interaction” and “Overdose” compared to other inotropes. Fatal outcomes were reported in 19 cases related to drug interactions and 41 cases related to overdose. Consistent disproportionality signals were found for gastrointestinal, renal, and nervous system disorders. Off-label use was reported in 0.8% of cases and was associated with unfavorable clinical outcomes. Risks are exacerbated by polypharmacy and renal decline in elderly patients.
Conclusions
Digoxin toxicity and cardiac complications are the primary drivers of reported morbidity. This risk profile highlights the need for the rigorous clinical monitoring, precise dose adjustments and heightened vigilance regarding drug–drug interactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.
- Department of Cardiology, County Clinical Emergency Hospital, 550245 Sibiu, Romania.
- Department of Cardiology, Vth Medical Clinic, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400139 Cluj-Napoca, Romania.
- Department of Endocrinology, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 3-5 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
- Preclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.
ORCID-Profile: Laurentiu Stoicescu, Ioana Rada Popa Ilie, Anca Butuca, Carmen Maximiliana Dobrea, Adina Frum, Claudiu Morgovan, Florina Batar, Crina Cristina Solomon, Felicia Gabriela Gligor
Förderung
- Lucian Blaga University of Sibiu
- “Lucian Blaga” University of Sibiu
Zitieren
APA
Fiat, E. S., Stoicescu, L., Popa Ilie, I. R., Vonica, R. C., Butuca, A., Dobrea, C. M., Frum, A., Morgovan, C., Batar, F., Solomon, C. C., & Gligor, F. G. (2026). Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis. Journal of Clinical Medicine, 15(15), 5983. https://doi.org/10.3390/jcm15155983
Vancouver
Fiat ES, Stoicescu L, Popa Ilie IR, Vonica RC, Butuca A, Dobrea CM, et al. Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis. Journal of Clinical Medicine. 2026;15(15):5983. doi:10.3390/jcm15155983
BibTeX
@article{Fiat2026,
author = {Fiat, Emilia Sorina and Stoicescu, Laurentiu and Popa Ilie, Ioana Rada and Vonica, Razvan Constantin and Butuca, Anca and Dobrea, Carmen Maximiliana and Frum, Adina and Morgovan, Claudiu and Batar, Florina and Solomon, Crina Cristina and Gligor, Felicia Gabriela},
title = {Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5983},
doi = {10.3390/jcm15155983}
}
EUVIMED